Evaluation of Probiotic Properties and Prebiotic Utilization Potential of Weissella paramesenteroides Isolated From Fruits
Weissella paramesenteroides has gained a considerable attention as bacteriocin and exopolysaccharide producers. However, potential of W. paramesenteroides to utilize different prebiotics is unexplored area of research. Fruits being vectors of various probiotics, five W. paramesenteroides strains, namely, FX1, FX2, FX5, FX9, and FX12, were isolated from different fruits. They were screened and selected based on their ability to survive at pH 2.5 and in 1.0% sodium taurocholate, high cell surface hydrophobicity, mucin adhesion, bile-induced biofilm formation, antimicrobial activity (AMA) against selected enteropathogens, and prebiotic utilization ability, implicating the functional properties of these strains. In vitro safety evaluation showed that strains were susceptible to antibiotics except vancomycin and did not harbor any virulent traits such as biogenic amine production, hemolysis, and DNase production. Based on their functionality, two strains FX5 and FX9 were selected for prebiotic utilization studies by thin layer chromatography (TLC) and short-chain fatty acids (SCFAs) production by high performance liquid chromatography. TLC profile evinced the ability of these two strains to utilize low molecular weight galactooligosaccharides (GOS) and fructooligosaccharides (FOS), as only the upper low molecular weight fractions were disappeared from cell-free-supernatants (CFS). Enhanced β-galactosidase activity correlated with galactose accumulation in residual CFS of GOS displayed GOS utilization ability. Both the strains exhibited AMA against E. coli and Staph. aureus and high SCFAs production in the presence of prebiotic, suggesting their synbiotic potential. Thus, W. paramesenteroides strains FX5 and FX9 exhibit potential probiotic properties with prebiotic utilization and can be taken forward to evaluate synergistic synbiotic potential in detail.
KeywordsWeissella paramesenteroides Probiotics Prebiotics Antimicrobial activity Short-chain fatty acids
This work was funded by the University Grant Commission (UGC), Government of India, under Major Research Project Scheme (MRP-Major-MICR-2013-35872). Ms. Kinjal Pabari is thankful to UGC for providing research fellowship. Authors would like to thank Center of Excellence (CoE) in Drug Discovery, Saurashtra University, Gujarat, for providing facility for HPLC analysis. Authors are grateful to Friesland Campina, the Netherlands for providing Vivinal GOS and Sweet Town Biotech, Taiwan for providing XOS.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 2.Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66 CrossRefPubMedGoogle Scholar
- 3.Lievin-Le Moal V, Servin AL (2014) Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev 27:167–199. https://doi.org/10.1128/CMR.00080-13 CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14:491–502. https://doi.org/10.1038/nrgastro.2017.75 CrossRefPubMedGoogle Scholar
- 9.Goh YJ, Klaenhammer TR (2015) Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes. Annu Rev Food Sci Technol 6:137–156. https://doi.org/10.1146/annurev-food-022814-015706 CrossRefPubMedGoogle Scholar
- 10.Veereman-Wauters G, Staelens S, Van de Broek H, Plaskie K, Wesling F, Roger L, McCartney A, Assam P (2011) Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J Pediatr Gastroenterol Nutr 52:763–771. https://doi.org/10.1097/mpg.0b013e3182139f39 CrossRefPubMedGoogle Scholar
- 11.Kolida S, Gibson GR (2011) Synbiotics in health and disease. Annu Rev Food Sci Technol 2:373–393. https://doi.org/10.1146/annurev-food-022510-133739 CrossRefPubMedGoogle Scholar
- 14.Singh S, Bhatia R, Singh A, Singh P, Kaur R, Khare P, Purama RK, Boparai RK, Rishi P, Ambalam P, Bhadada SK, Bishnoi M, Kaur J, Kondepudi KK (2018) Probiotic attributes and prevention of LPS-induced pro-inflammatory stress in RAW264.7 macrophages and human intestinal epithelial cell line (Caco-2) by newly isolated Weissella cibaria strains. Food Funct 9:1254–1264. https://doi.org/10.1039/c7fo00469a CrossRefPubMedGoogle Scholar
- 22.Ambalam P, Kondepudi KK, Balusupati P, Nilsson I, Wadstrom T, Ljungh Å (2015) Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile. J Appl Microbiol 119:1672–1682. https://doi.org/10.1111/jam.12953 CrossRefPubMedGoogle Scholar
- 24.Collins MD, Samelis J, Metaxopoulos J, Wallbanks S (1993) Taxonomic studies on some leuconostoc-like organisms from fermented sausages: description of a new genus Weissella for the Leuconostoc paramesenteroides group of species. J Appl Microbiol 75:595–603. https://doi.org/10.1111/j.1365-2672.1993.tb01600.x CrossRefGoogle Scholar
- 26.Ku HJ, Kim YT, Lee JH (2017) Genomic insights of Weissella jogaejeotgali FOL01T reveals its food fermentation ability and human gut adaptive potential for probiotic applications in food industries. J Microbiol Biotechnol 27:943–946. https://doi.org/10.4014/jmb.1702.02054 CrossRefPubMedGoogle Scholar
- 28.Xiong L, Ni X, Niu L, Zhou Y, Wang Q, Khalique A, Liu Q, Zeng Y, Shu G, Pan K, Jing B (2019) Isolation and preliminary screening of a Weissella confusa strain from giant panda (Ailuropoda melanoleuca). Probiotics Antimicrob Proteins 11:535–544. https://doi.org/10.1007/s12602-018-9402-2 CrossRefPubMedGoogle Scholar
- 33.Ramiah K, van Reenen CA, Dicks LM (2009) Expression of the mucus adhesion gene mub, surface layer protein slp and adhesion-like factor EF-TU of Lactobacillus acidophilus ATCC 4356 under digestive stress conditions, as monitored with real-time PCR. Probiotics Antimicrob Proteins 1:91–95. https://doi.org/10.1007/s12602-009-9009-8 CrossRefPubMedGoogle Scholar
- 36.Joint FAO (2002) Guidelines for the evaluation of probiotics in food, London, Ontario, Canada. April 30 and May 1, 2002Google Scholar